Technical Data
D1560-01B
DDAH2 (DDAHII, DDAH, Dimethylarginine Dimethylaminohydrolase 2, Dimethylargininase 2, G6a, NG30, Protein G6a, S-Phase Protein)
Description:
DDAH2 plays a role in nitric oxide generation by regulating cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity. Overexpression of DDAH2 has also been linked to increased VEGF mRNA expression and enhanced tube formation by cells grown in a 3-dimensional medium.

Applications:
Suitable for use in Western Blot. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20C. Aliquots are stable for at least 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
PabIgGPurified
SizeStorageShippingSourceHost
100ug-20CBlue IceHumanGoat
Concentration:
~0.5mg/ml
Immunogen:
Peptide with the sequence SSLCLVLSTRPHS from the C terminus of the protein (NP_039268).
Purity:
Purified
Form
Supplied as a liquid in Tris-saline, 0.02% sodium azide, 0.5% BSA.
Specificity:
Recognizes human DDAH2.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.